Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

13912

Limits Of Fundus-based Deep Learning For Alzheimer’S Disease Prediction: Anatomical Ablation And Clinical Benchmarking In Uk Biobank

Part of Topic

Biomarkers -> Biomarkers (non-neuroimaging) -> Digital Health Technologies / Digital Biomarkers

Limits of Fundus-Based Deep Learning for Alzheimer’s Disease Prediction: Anatomical Ablation and Clinical Benchmarking in UK Biobank

To evaluate retinal fundus imaging for predicting Alzheimer’s Disease and Related Dementias (ADRD) using a pretrained retinal foundation model (RETFound), including assessment of model performance from baseline models, retinal region contributions, and added value beyond demographic risk factors. 

  • The retina reflects brain neurobiology through neuromodulator release while retinal ganglion cell-inner plexiform layer (GC-IPL) and retinal nerve fiber layer (RNFL) thinning contributes to blood vessel inflammation and impaired exchange of nutrients, and wastes linking retinal changes to systemic neurodegeneration and cognitive decline.
  • Instead of using costly and labor intensive traditional MRI scans for Alzheimer’s Disease diagnosis, fundus images and OCT scans in the eye can potentially provide a cheap and efficient alternative for providing accessible and equal care among people and communities.
  • The retina is a non-invasive biomarker for ADRD. Optical coherence tomography (OCT) studies show thin RNFL and GC-IPL are associated with higher dementia risk and poorer cognition in large cohorts (e.g. UK Biobank), establishing retinal structure as a marker of cognitive decline.
  • Advances in machine learning (ML) have shifted ADRD research from traditional models to deep learning. Neural networks extract complex image features, and models using retinal and vascular biomarkers achieve strong performance (average AUC to ~0.85)
  • RETFound is a pretrained retinal foundation model trained on 1.6M+ retinal images. Its self-supervised framework enables efficient fine-tuning. We apply RETFound to UK Biobank fundus images and clinical variables to evaluate ADRD prediction against baseline models, trained using nature images, and custom sigmoidal multimodal fusion model.
  • OCT Logistic Regression (LR) acts as clinical baseline using age, sex and human derived GC-IPL and RNFL numerical values from fundus images. Human derived variables are very labor intensive and are not ideal for mass data.
Results:
RETFound improved fundus-based ADRD prediction over traditional deep learning methods by 0.08 in AUROC, but performance remained limited by class imbalance and subtle retinal signal, with traditional OCT-derived biomarkers still outperforming all image-based models.
Discussion:
  • RETFound performance: RETFound outperformed ImageNet models, supporting the value of retinal-specific pretraining, though overall performance remained moderate.
  • Vessel as a retinal signal: Ablation analysis showed predictive features are not localized; vessel images performed comparably to full fundus, while macula images underperformed, supporting physiology behind retina and dementia
  • Impact of class imbalance: Performance was sensitive to sampling strategies. Oversampling with focal loss provided balanced results, while other methods shifted sensitivity–specificity trade-offs, affecting clinical usability
  • Comparison to clinical features: OCT-derived biomarkers (e.g., GC-IPL, RNFL) outperformed image-based models, indicating fundus imaging may serve as a complementary rather than standalone tool
  • Clinical relevance: Despite low AUPRC due to rare disease prevalence, models showed enrichment over baseline, suggesting potential utility in screening settings. However, achieving clinically acceptable sensitivity and specificity remains challenging.
Limitations:
  • Class imbalance: Low ADRD prevalence led to imbalance despite mitigation, contributing to low AUPRC and prediction difficulty
  • Modest performance: AUROC was moderate, suggesting limited predictive signal from fundus images alone and possible label limitations
  • Preprocessing & generalizability: Image representationsused heuristic methods rather than precise segmentation. Models were trained only on UK Biobank
  • Limited multimodal data: Only demographics were included; additional expert-guided features may improve performance and interpretability

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.